| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.006 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.006 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.007 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.007 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.009 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |